IRMD Iradimed Corp

iRadimed Corp develops, manufactures, markets and distributes Magnetic Resonance Imaging compatible products to acute care facilities and outpatient imaging centers, both in the United States and internationally.

$28.00  -1.05 (-3.61%)
As of 05/10/2021 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  07/16/2014
Outstanding shares:  12,312,371
Average volume:  16,712
Market cap:   $357,674,378
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    46266A109
ISIN:        US46266A1097
Sedol:      BP4GNJ8
Valuation   (See tab for details)
PE ratio:   349.42
PB ratio:   5.47
PS ratio:   11.09
Return on equity:   1.56%
Net income %:   3.06%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy